NCT04937647 Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy
| NCT ID | NCT04937647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Portsmouth Hospitals NHS Trust |
| Condition | Gastrointestinal Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,650 participants |
| Start Date | 2021-06-16 |
| Primary Completion | 2026-06-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,650 participants in total. It began in 2021-06-16 with a primary completion date of 2026-06-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.
Eligibility Criteria
Inclusion Criteria: -The participant must meet ALL of the following criteria to be considered eligible for the study: * Male or Female, aged 18 years or above. * Requiring gastroscopy and/or colonoscopy to investigate gastrointestinal symptoms, or as part of screening or ongoing surveillance of GI neoplasia. * Participant is willing and able to give informed consent for participation in the study. Exclusion Criteria The participant may not enter the study if ANY of the following apply: * Patients with endoscopically active severe oesophagitis * Poor bowel preparation
Contact & Investigator
Pradeep Bhandari, Prof
PRINCIPAL INVESTIGATOR
Portsmouth Hospitals NHS Trust
Frequently Asked Questions
Who can join the NCT04937647 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastrointestinal Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04937647 currently recruiting?
Yes, NCT04937647 is actively recruiting participants. Contact the research team at Laura.Marshall2@porthosp.nhs.uk for enrollment information.
Where is the NCT04937647 trial being conducted?
This trial is being conducted at Portsmouth, United Kingdom.
Who is sponsoring the NCT04937647 clinical trial?
NCT04937647 is sponsored by Portsmouth Hospitals NHS Trust. The principal investigator is Pradeep Bhandari, Prof at Portsmouth Hospitals NHS Trust. The trial plans to enroll 1,650 participants.